Supernus Pharmaceuticals (S49.F) Q4 2024 Earnings

Nov 4Confirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
0
0.36
0.72
1.07

Details

Expected EPS
0.40760036019999996
Actual EPS
1.0742563807999999
Surprise EPS
0.67
Surprise Percent
+163.56%

Description

⁨Supernus Pharmaceuticals⁩ (⁦S49.F⁩) has reported earnings of ⁦1.0742563807999999⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts